Premier Resolution System

FDA 510(k) K222635 · Trinity Biotech (Primus Corporation, Dba Trinity Biotech)

Substantially Equivalent

510(k) numberK222635

Submission

Device name
Premier Resolution System
Applicant
Trinity Biotech (Primus Corporation, Dba Trinity Biotech)
Kansas City, MO, US
Received
August 31, 2022
Decision date
August 4, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GKA – Abnormal Hemoglobin Quantitation
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7415
Specialty
Hematology

Other 510(k)s with product code GKA

510(k)DeviceApplicantDecision
K232027CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentGKA · Traditional Sebia04/04/2024SE
K192931V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo ControlGKA · Traditional Helena Laboratories, Corp.04/19/2022SE
K180762Capi 3 Hemoglobin(E)GKA · Traditional Sebia12/14/2018SE
K171664Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview SoftwareGKA · Special Bio-Rad Laboratories, Inc.09/13/2017SE
K112550Capillarys Hemoglobin, Capillarys Flex Piercing SystemGKA · Traditional Sebia05/25/2012SE
K112491Sebia Capillarys Hemoglobin(E) with Capillarys 2GKA · Traditional Sebia05/24/2012SE
K091283Capillarys Neonat HB (PN 2006)GKA · Traditional Sebia02/22/2010SE
K082227Minicap Hemoglobin(E) Kit, Model 2207, 2227GKA · Traditional Sebia03/26/2009SE
K080911Variant NBS Sickle Cell Program Reagent Kit, Variant NBS Newborn Screening System and…GKA · Special Bio-Rad Laboratories Inc., Clinical Systems Divisi05/02/2008SE
K052291Capillary's Hemoglobin(E) (PN 2007)GKA · Traditional Sebia06/27/2006SE

Questions and answers

When was Premier Resolution System cleared by the FDA?

Premier Resolution System (K222635) received a 510(k) decision of Substantially Equivalent on August 4, 2023, 338 days after the submission was received.

What is the product code of K222635?

The FDA product code is GKA – Abnormal Hemoglobin Quantitation, a Class II (moderate risk) device regulated under 21 CFR 864.7415.